Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.37 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.36 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | SCN1A | P35498 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27104595 | 0.94 | ALDH1A1 (0.44) | ALDH1A1KDM4ESIGMAR1HPGDCYP1A2 | |
| SCHEMBL13187933 | 0.89 | KDM4E (0.57) | ALDH1A1KDM4EHPGDGLAHSD17B10 | |
| SCHEMBL27220456 | 0.89 | KDM4E (0.57) | ALDH1A1KDM4EHPGDGLAHSD17B10 | |
| SCHEMBL10401216 | 0.87 | ALDH1A1 (0.43) | ALDH1A1KDM4ESIGMAR1HPGDCYP1A2 | |
| SCHEMBL23223379 | 0.85 | SIGMAR1 (0.40) | ALDH1A1KDM4ESIGMAR1CYP1A2MAPK1 | |
| SCHEMBL20628217 | 0.84 | KDM4E (0.52) | ALDH1A1KDM4EHPGDGLAHSD17B10 | |
| SCHEMBL18379164 | 0.83 | SIGMAR1 (0.48) | SIGMAR1HPGDCYP1A2MAPK1CYP2C9 | |
| SCHEMBL28502711 | 0.80 | ALDH1A1 (0.38) | ALDH1A1KDM4ESIGMAR1CYP1A2MAPK1 | |
| SCHEMBL1133412 | 0.79 | KEAP1 (0.50) | ALDH1A1KDM4ESIGMAR1HPGDCYP1A2 | |
| SCHEMBL1034010 | 0.78 | KDM4E (0.50) | ALDH1A1KDM4ESIGMAR1HPGDGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2026-04-16 | — | — | US | disclosed |
| US-12508226-B2 | Lipid composition | FUJIFILM CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| US-12370143-B2 | Compound or salt thereof and lipid particles | FUJIFILM CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| EP-4328309-B1 | LIPID COMPOSITION | FUJIFILM CORP (JP) | 2025-07-02 | — | — | EP | disclosed |
| US-12285525-B2 | Compound or salt thereof and lipid particles | FUJIFILM CORPORATION (JP) | 2025-04-29 | — | — | US | disclosed |
| CN-116172975-B | Lipid particle, nucleic acid drug comprising same, and composition for nucleic acid delivery | 富士胶片株式会社 | 2025-03-28 | — | — | CN | disclosed |
| CN-114728016-B | Lipid composition | 富士胶片株式会社 | 2024-10-29 | — | — | CN | disclosed |
| US-20240315970-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2024-09-26 | — | — | US | disclosed |
| CN-113924128-B | Lipid composition | 富士胶片株式会社 | 2024-09-06 | — | — | CN | disclosed |
| EP-4328309-A2 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2024-02-28 | — | — | EP | disclosed |
| CN-114728016-A | Lipid composition | 富士胶片株式会社 | 2022-07-08 | — | — | CN | disclosed |
| EP-3981435-A1 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2022-04-13 | — | — | EP | disclosed |
| US-20220096381-A1 | LIPID COMPOSITION | FUJIFILM CORPORATION (JP) | 2022-03-31 | — | — | US | disclosed |
| CN-113924128-A | Lipid composition | 富士胶片株式会社 | 2022-01-11 | — | — | CN | disclosed |
| WO-2021095876-A1 | LIPID COMPOSITION | 富士フイルム株式会社 | 2021-05-20 | — | — | WO | disclosed |
| EP-3805198-A1 | COMPOUND, SALT THEREOF AND LIPID PARTICLES | FUJIFILM Corporation (JP) | 2021-04-14 | — | — | EP | disclosed |
| US-20210085604-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2021-03-25 | — | — | US | disclosed |
| US-20210085604-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2021-03-25 | — | — | US | disclosed |
| CN-112262122-A | Compound or salt thereof, and lipid particle | 富士胶片株式会社 | 2021-01-22 | — | — | CN | disclosed |
| WO-2020246581-A1 | LIPID COMPOSITION | 富士フイルム株式会社 | 2020-12-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12370143-B2 | Compound or salt thereof and lipid particles | NR1H3, NR1H2, LDLR | ALDH1A1 2243/4885KDM4E 3138/4885SIGMAR1 24/4885 |
| US-12285525-B2 | Compound or salt thereof and lipid particles | NR1H3, NR1H2, LDLR | ALDH1A1 2243/4885KDM4E 3138/4885SIGMAR1 24/4885 |
| US-20240315970-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | NR1H3, NR1H2, LDLR | ALDH1A1 2243/4885KDM4E 3138/4885SIGMAR1 24/4885 |
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | LDLR, NR1H3, NR1H2 | ALDH1A1 2418/4885KDM4E 3995/4885SIGMAR1 52/4885 |
| US-20210085604-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | NR1H3, NR1H2, LDLR | ALDH1A1 2368/4885KDM4E 3119/4885SIGMAR1 25/4885 |
| US-20220096381-A1 | LIPID COMPOSITION | NR1H3, NR1H4, NR1H2 | ALDH1A1 3097/4885KDM4E 3538/4885SIGMAR1 26/4885 |
| US-12508226-B2 | Lipid composition | APOB, NAF1, SLC27A1 | ALDH1A1 2907/4885KDM4E 3879/4885SIGMAR1 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.